PFIZER INC. (LON:PFZ) Files An 8-K Results of Operations and Financial Condition
Item 2.02 Results of Operations and Financial Condition
On January29, 2019, Pfizer Inc. (“Pfizer”) issued a press release announcing its financial results for the fourth quarter and full-year 2018. A copy of the press release is furnished herewith as Exhibit 99 and is incorporated by reference herein.
The information furnished to this “Item 2.02 – Results of Operations and Financial Condition”, including Exhibit 99, shall not be deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (“Exchange Act”) or otherwise subject to the liabilities of that section, and shall not be deemed to be incorporated by reference into any filing made by us under the Exchange Act or Securities Act of 1933, as amended, regardless of any general incorporation language in any such filing, except as shall be expressly set forth by specific reference in such filing.
Item 9.01 Financial Statements and Exhibits
(d)Exhibits
|
Exhibit Number |
Exhibit Description |
|
Press Release of Pfizer Inc. dated January 29, 2019, reporting Pfizer’s financial results for fourth-quarter and full-year 2018. |
|
EXHIBIT INDEX |
|
|
Exhibit No. |
Description |
|
Press Release of Pfizer Inc. dated January 29, 2019, reporting Pfizer’s financial results for fourth-quarter and full-year 2018. |
PFIZER INC Exhibit
EX-99.1 2 pfe-12312018xex99.htm EXHIBIT 99.1 Exhibit Exhibit 99PFIZER REPORTS FOURTH-QUARTER AND FULL-YEAR 2018 RESULTSPROVIDES 2019 FINANCIAL GUIDANCE▪Full-Year 2018 Revenues of $53.6 Billion,…
To view the full exhibit click here
